ReviewProstate cancer and prostatic diseases2019
MRI in active surveillance: a critical review.
Review in Prostate cancer and prostatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.
- Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis.Prostate cancer and prostatic diseases · 2019Pooled it
- In-bore MRI-guided prostate biopsy: current evidence, clinical applications, and future directions.Polish journal of radiology · 2026Review
- Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [Scientific reports · 2024Article
- Semisupervised Learning with Report-guided Pseudo Labels for Deep Learning-based Prostate Cancer Detection Using Biparametric MRI.Radiology. Artificial intelligence · 2023Article
- mpMRI Interpretation in Active Surveillance for Prostate Cancer-An overview of the PRECISE score.Abdominal radiology (New York) · 2023Review
- Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarizedMagnetic resonance in medicine · 2022Article
- Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022Article
- Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.The Prostate · 2022Article
- National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed, modified Delphi survey of Canadian urologists/radiation oncologists.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022Article
- Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.Journal of the National Comprehensive Cancer Network : JNCCN · 2022Article
- Patient- and tumor-level risk factors for MRI-invisible prostate cancer.Prostate cancer and prostatic diseases · 2021Article
- Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 EraThe world journal of men's health · 2021Article
- Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.Korean journal of radiology · 2021Review
- Active surveillance for prostate cancer-will the discoveries of the last 5 years change the future?Translational andrology and urology · 2021Article
- Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI.European radiology · 2020Article
- Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.International journal of clinical oncology · 2020Review
- Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.Investigative and clinical urology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
introductionRecent technological advancements and the introduction of modern anatomical and functional sequences have led to a growing role for multiparametric magnetic resonance imaging (mpMRI) in the detection, risk assessment and monitoring of early prostate cancer. This includes men who have been diagnosed with lower-risk prostate cancer and are looking at the option of active surveillance (AS). The purpose of this paper is to review the recent evidence supporting the use of mpMRI at different time points in AS, as well as to discuss some of its potential pitfalls.
methodsA combination of electronic and manual searching methods were used to identify recent, important papers investigating the role of mpMRI in AS.
resultsThe high negative predictive value of mpMRI can be exploited for the selection of AS candidates. In addition, mpMRI can be efficiently used to detect higher risk disease in patients already on surveillance.
conclusionAlthough there is an ongoing debate regarding the precise nature of its optimal implementation, mpMRI is a promising risk stratification tool and should be considered for men on AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.